Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Regenxbio Inc (NASDAQ: RGNX) was $9.53 for the day, down -0.83% from the previous closing price of $9.61. In other words, the price has decreased by -$0.83 from its previous closing price. On the day, 0.85 million shares were traded. RGNX stock price reached its highest trading level at $10.06 during the session, while it also had its lowest trading level at $9.27.
Ratios:
Our analysis of RGNX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 2.93. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Neutral and sets its target price to $14 from $38 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 12 ’25 when Mills Kenneth T. sold 20,602 shares for $7.91 per share. The transaction valued at 163,046 led to the insider holds 475,103 shares of the business.
KENNETH MILLS bought 20,602 shares of RGNX for $154,927 on May 12 ’25. On Dec 30 ’24, another insider, VITTAL VASISTA, who serves as the Officer of the company, bought 20,041 shares for $7.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGNX now has a Market Capitalization of 482040736 and an Enterprise Value of 343685152. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.05 while its Price-to-Book (P/B) ratio in mrq is 1.74. Its current Enterprise Value per Revenue stands at 2.193 whereas that against EBITDA is -2.431.
Stock Price History:
The Beta on a monthly basis for RGNX is 1.09, which has changed by -0.29823267 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, RGNX has reached a high of $15.36, while it has fallen to a 52-week low of $5.03. The 50-Day Moving Average of the stock is 16.40%, while the 200-Day Moving Average is calculated to be 7.58%.
Shares Statistics:
RGNX traded an average of 1.17M shares per day over the past three months and 1405200 shares per day over the past ten days. A total of 50.12M shares are outstanding, with a floating share count of 45.45M. Insiders hold about 9.39% of the company’s shares, while institutions hold 87.56% stake in the company. Shares short for RGNX as of 1747267200 were 6303414 with a Short Ratio of 5.38, compared to 1744675200 on 5250816. Therefore, it implies a Short% of Shares Outstanding of 6303414 and a Short% of Float of 15.28.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
